ME1 and ovarian carcinoma: Further validation through more in-depth in vivo studies, animal models, and clinical trials, supported by multi-omics approaches, is needed to comprehensively elucidate the role of ME1 in ovarian cancer metabolism and immunity, thereby facilitating the translation from basic research to clinical application.